Targeting the cell cycle for cancer therapy: From the discovery of CDK9 to precision medicine and beyond
More than 30 years after the direct connection was established between the molecular machinery controlling cell division and cancer, a new paper traces the evolution of cyclin-dependent kinase research and outlines the next generation of CDK-targeted therapies.
Read original article on Phys.org - latest science and technology news stories →Related news
-
Building trust in governments through digital platforms
-
Molecular snapshots reveal how viral enzymes switch between inserting and removing DNA
- It's Official: Timekeepers Have Gotten Rid of the Leap Second—and Introduced the Leap Hour Instead
-
Single 2D crystal transforms into transistor with built-in insulation and electrical contacts
-
EcoFlow’s new TITAN batteries can keep your central air running through a blackout
-
AI turns scrap impurities into useful ingredients for stronger recycled iron
-
The little‑known 14th-century battle that has shaped English, Scottish and French relations
-
/https://tf-cmsv2-smithsonianmag-media.s3.amazonaws.com/filer_public/b7/1f/b71fa290-10a4-4a87-a534-76778a166a9e/1960x0_1.webp)
On an Island Outside Paris, a Sprawling Contemporary Arts Center Aptly Called 'Large' Prepares to Open Its Doors